Disclosure Plus

"MOA Life Plus Faces Delisting Concerns Due to Share Price Falling Below Threshold"

Shin Ha-yeon
2026-11-05 17:43:07
[Edaily Reporter Shin Ha-yeon ] The KOSDAQ Market Division of the Korea Exchange announced on the 5th that there are concerns regarding the delisting of MOA Life Plus(142760)due to its stock price falling below the required threshold.

MOA Life Plus was designated as a “monitored stock” after its closing price remained below 1,000 won for 30 consecutive trading days as of September 4. As of today, 41 trading days have passed since the designation, and the number of consecutive days on which the closing price has met or exceeded 1,000 won is zero.

The company stated, “If the closing price of common stock remains below 1,000 won for five consecutive days, the company may be delisted.”

Economy

Corporation

IT·Science

Economy

“We Pay Interest First”… Kbank Deposits Surge by 1.1 Trillion Won in Just One Month

#Kbank’s new fixed-term deposit product, which allows customers to choose when they receive interest, has surpassed 1.1 trillion won in new deposits within just one month. With this product, customers…
2026-11-06 10:41:18

Corporation

Shinsegae Co.,Ltd Appoints Lee Seok-gu as New Head of Department Store Division… “To Strengthen Audit Functions”

Shinsegae Co.,Ltd has appointed Lee Seok-gu, the current CEO of Shinsegae DF, as the new head of its department store division. Through this appointment, the Shinsegae Department Store Division plans …
2026-11-06 11:09:25

IT·Science

Next Year Will Be Decisive for Aptabio Therapeutics Inc.’s New Kidney Drug… CEO Lee Soo-jin: “65% Enrollment in Phase 2b Trial”

Aptabio Therapeutics Inc.(293780)has completed approximately 65% of patient enrollment for the domestic Phase 2b clinical trial of “Isuzinacxib” (APX-115), a treatment for diabetic nephropathy. As it …
2026-11-06 11:02:02